Delivery of Neurotrophin-3 by RVG-Lamp2b-modified Mesenchymal Stem Cell-derived Exosomes Alleviates Facial Nerve Injury

Overview

Journal Hum Cell

Publisher Springer

Specialty Cell Biology

Date 2024 Jun 10

PMID 38858338

Authors

Wenting Bi

Xiaodan Mu

Yongfeng Li

Qingyan Sun

Lei Xiang

Min Hu

Huawei Liu

Affiliations

Soon will be listed here.

Abstract

We aim to investigate the effect of RVG-Lamp2b-modified exosomes (exos) loaded with neurotrophin-3 (NT-3) on facial nerve injury. Exos were collected from control cells (Ctrl Exo) or bone marrow mesenchymal stem cells co-transfected with RVG-Lamp2b and NT-3 plasmids (RVG-NT-3 Exo) by gradient centrifugation and identified by western blotting, transmission electron microscopy, and nanoparticle tracking analysis. Effect of RVG-NT-3 Exo on oxidative stress damage was determined by analysis of the morphology, viability, and ROS production of neurons. Effect of RVG-NT-3 Exo on facial nerve axotomy (FNA) was determined by detecting ROS production, neuroinflammatory reaction, microglia activation, facial motor neuron (FMN) death, and myelin sheath repair. Loading NT-3 and modifying with RVG-Lamp2b did not alter the properties of the exos. Moreover, RVG-NT-3 Exo could effectively target neurons to deliver NT-3. Treatment with RVG-NT-3 Exo lowered HO-induced oxidative stress damage in primary neurons and Nsc-34 cells. RVG-NT-3 Exo treatment significantly decreased ROS production, neuroinflammatory response, FMN death, and elevated microglia activation and myelin sheath repair in FNA rat models. Our findings suggested that RVG-NT-3 Exo-mediated delivery of NT-3 is effective for the treatment of facial nerve injury.

References

Schroeter F, Amyai N, Petignat P, Wicki B . [Facial palsy: diagnostic traps]. Rev Med Suisse. 2023; 19(836):1413-1418. DOI: 10.53738/REVMED.2023.19.836.1413. View

Kinoshita I, Kawata R, Higashino M, Terada T, Haginomori S, Tochizawa T . Tumor localization is the important factor for recovery time of postoperative facial nerve paralysis in benign parotid surgery. Auris Nasus Larynx. 2023; 51(1):214-220. DOI: 10.1016/j.anl.2023.07.002. View

Zhou H, Yu S, Wu P . Analyzing the impact of sustainable economic development from the policy text network: Based on the practice of China's bay area policy. PLoS One. 2023; 18(12):e0296256. PMC: 10756538. DOI: 10.1371/journal.pone.0296256. View

Tawfik H, Dutton J . Facial Nerve Palsy and the Eye: Etiology, Diagnosis, and Management. Int Ophthalmol Clin. 2023; 63(3):75-94. DOI: 10.1097/IIO.0000000000000457. View

Lee J, Choi Y, Yoo M, Yeo S . Central Facial Nervous System Biomolecules Involved in Peripheral Facial Nerve Injury Responses and Potential Therapeutic Strategies. Antioxidants (Basel). 2023; 12(5). PMC: 10215271. DOI: 10.3390/antiox12051036. View

Yamashita N . Retrograde signaling via axonal transport through signaling endosomes. J Pharmacol Sci. 2019; 141(2):91-96. DOI: 10.1016/j.jphs.2019.10.001. View

Hernandez-Echeagaray E . Neurotrophin-3 modulates synaptic transmission. Vitam Horm. 2020; 114:71-89. DOI: 10.1016/bs.vh.2020.04.008. View

Rocco M, Soligo M, Manni L, Aloe L . Nerve Growth Factor: Early Studies and Recent Clinical Trials. Curr Neuropharmacol. 2018; 16(10):1455-1465. PMC: 6295934. DOI: 10.2174/1570159X16666180412092859. View

Puhl D, Funnell J, Fink T, Swaminathan A, Oudega M, Zha R . Electrospun fiber-mediated delivery of neurotrophin-3 mRNA for neural tissue engineering applications. Acta Biomater. 2022; 155:370-385. DOI: 10.1016/j.actbio.2022.11.025. View

10.

Wang X, Gu P, Chen S, Gao W, Tian H, Lu X . Endogenous neurotrophin-3 promotes neuronal sprouting from dorsal root ganglia. Neural Regen Res. 2016; 10(11):1865-8. PMC: 4705803. DOI: 10.4103/1673-5374.170318. View

11.

Wan H, Zhang L, Blanchard S, Bigou S, Bohl D, Wang C . Combination of hypoglossal-facial nerve surgical reconstruction and neurotrophin-3 gene therapy for facial palsy. J Neurosurg. 2013; 119(3):739-50. DOI: 10.3171/2013.1.JNS121176. View

12.

Wang H, Ni H, Han S, Xu W, Wang J, Yuan B . The Promotion of Neural Regeneration in A Rat Facial Nerve Crush Injury Model Using Collagen-Binding NT-3. Ann Clin Lab Sci. 2016; 46(6):578-585. View

13.

Li G, Che M, Zhang K, Qin L, Zhang Y, Chen R . Graft of the NT-3 persistent delivery gelatin sponge scaffold promotes axon regeneration, attenuates inflammation, and induces cell migration in rat and canine with spinal cord injury. Biomaterials. 2016; 83:233-48. DOI: 10.1016/j.biomaterials.2015.11.059. View

14.

Yao S, Rong W, Yuan Y . Optimization of adeno-associated virus (AAV) gene delivery into human bone marrow stem cells (hBMSCs). Stem Cell Investig. 2023; 10:3. PMC: 9905037. DOI: 10.21037/sci-2022-042. View

15.

Tenchov R, Sasso J, Wang X, Liaw W, Chen C, Zhou Q . Exosomes─Nature's Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. ACS Nano. 2022; 16(11):17802-17846. PMC: 9706680. DOI: 10.1021/acsnano.2c08774. View

16.

Szablowska-Gadomska I, Rudzinski S, Dymowska M . Secretome of Mesenchymal Stromal Cells as a Possible Innovative Therapeutic Tool in Facial Nerve Injury Treatment. Biomed Res Int. 2023; 2023:8427200. PMC: 9867597. DOI: 10.1155/2023/8427200. View

17.

Liang Y, Duan L, Lu J, Xia J . Engineering exosomes for targeted drug delivery. Theranostics. 2021; 11(7):3183-3195. PMC: 7847680. DOI: 10.7150/thno.52570. View

18.

Ma J, Zhao Y, Sun L, Sun X, Zhao X, Sun X . Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D. Stem Cells Transl Med. 2017; 6(1):51-59. PMC: 5442756. DOI: 10.5966/sctm.2016-0038. View

19.

Tamura R, Uemoto S, Tabata Y . Augmented liver targeting of exosomes by surface modification with cationized pullulan. Acta Biomater. 2017; 57:274-284. DOI: 10.1016/j.actbio.2017.05.013. View

20.

Bauer A, Nolden T, Schroter J, Romer-Oberdorfer A, Gluska S, Perlson E . Anterograde glycoprotein-dependent transport of newly generated rabies virus in dorsal root ganglion neurons. J Virol. 2014; 88(24):14172-83. PMC: 4249153. DOI: 10.1128/JVI.02254-14. View